U.S., Sept. 23 -- ClinicalTrials.gov registry received information related to the study (NCT07833293) titled 'Effectiveness of AI-Assisted Antibiotic Prescribing' on Sept. 16.
Brief Summary: This randomized controlled trial aims to evaluate the impact of providing LLM access to physicians on antibiotic prescribing appropriateness, using a composite outcome instrument, the Antibiotic Prescribing Appropriateness Score (APAS), that simultaneously evaluates antibiotic selection, dosing, duration, clinical reasoning, and management planning. Participants will be randomly assigned to one of two groups: the intervention group will have access to an LLM alongside conventional resources, while the control group will use conventional resources only ...